Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
DSP-0390 by Sumitomo Pharma for Oligodendroglioma: Likelihood of Approval
DSP-0390 is under clinical development by Sumitomo Pharma and currently in Phase II for Oligodendroglioma. According to GlobalData, Phase II...
Data Insights
DSP-0390 by Sumitomo Pharma for Anaplastic Astrocytoma: Likelihood of Approval
DSP-0390 is under clinical development by Sumitomo Pharma and currently in Phase II for Anaplastic Astrocytoma. According to GlobalData, Phase...